Thymmune lands $37M from Biden`s ARPA-H for immune-rejuvenating therapies
29 Sep 2023 //
ENDPTS
Thymmune Receives $37M in Funding from National Institutes of Health`s ARPA-H
29 Sep 2023 //
BUSINESSWIRE
Thymmune Secures $7M in Seed Financing to Develop Thymus Cell Therapy Platform
01 Mar 2023 //
BUSINESSWIRE